DIMENSIONAL FUND ADVISORS LP - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 409 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$24,645,050
+17.8%
203,278
+11.2%
0.01%
+14.3%
Q2 2023$20,927,021
-19.9%
182,762
-3.6%
0.01%
-22.2%
Q1 2023$26,127,697
+104461.0%
189,585
-1.7%
0.01%
+28.6%
Q4 2022$24,988
-99.9%
192,870
+2.0%
0.01%
-12.5%
Q3 2022$20,901,000
+72.5%
189,086
+17.0%
0.01%
+100.0%
Q2 2022$12,115,000
-13.5%
161,590
-9.9%
0.00%0.0%
Q1 2022$14,007,000
-2.6%
179,294
+12.3%
0.00%0.0%
Q4 2021$14,375,000
-7.2%
159,634
-4.7%
0.00%
-20.0%
Q3 2021$15,483,000
+22.9%
167,457
+3.4%
0.01%
+25.0%
Q2 2021$12,596,000
-4.3%
162,017
-8.1%
0.00%0.0%
Q1 2021$13,164,000
-59.9%
176,362
-8.4%
0.00%
-66.7%
Q4 2020$32,822,000
+25.6%
192,509
+3.4%
0.01%
+9.1%
Q3 2020$26,140,000
-10.7%
186,136
+2.0%
0.01%
-15.4%
Q2 2020$29,270,000
+58.7%
182,528
-3.2%
0.01%
+30.0%
Q1 2020$18,449,000
-19.8%
188,601
+5.8%
0.01%
+25.0%
Q4 2019$22,998,000
+101.4%
178,232
+17.6%
0.01%
+100.0%
Q3 2019$11,417,000
-47.4%
151,577
+5.9%
0.00%
-50.0%
Q2 2019$21,715,000
+29.6%
143,102
+1.8%
0.01%
+14.3%
Q1 2019$16,758,000
-4.0%
140,602
-12.1%
0.01%
-12.5%
Q4 2018$17,465,000
-30.4%
160,044
+3.0%
0.01%
-20.0%
Q3 2018$25,102,000
+24.4%
155,442
+1.8%
0.01%
+25.0%
Q2 2018$20,186,000
+143.4%
152,700
+36.4%
0.01%
+166.7%
Q1 2018$8,295,000
+3850.0%
111,965
+1481.6%
0.00%
Q1 2017$210,0007,0790.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 112,689$14,541,00014.93%
Casdin Capital, LLC 670,000$86,457,0007.95%
Logos Global Management LP 226,002$29,163,0007.19%
Avoro Capital Advisors LLC 1,760,000$227,110,0006.67%
Camber Capital Management LP 600,000$77,424,0003.94%
STANSBERRY ASSET MANAGEMENT, LLC 71,133$9,179,0003.74%
Eventide Asset Management 996,000$128,524,0003.62%
CADIAN CAPITAL MANAGEMENT, LP 550,000$70,972,0003.14%
RTW INVESTMENTS, LP 605,762$78,168,0002.95%
Consonance Capital Management LP 356,145$45,957,0002.80%
View complete list of SAREPTA THERAPEUTICS INC shareholders